Lyell Immunopharma Inc
LYEL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$409.3M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $409.30 Million |
|---|---|
| Enterprise Value | $351.57 Million |
| Earnings per Share | $-16.06 |
| Beta | -0.07 |
| Outstanding Shares | 24,436,000 |
Return
| Return on Equity | -132.40% |
|---|---|
| Return on Assets | -93.17% |
| Return on Invested Capital | 58.97% |
Valuation & Multiples
| P/E Ratio | -0.94 |
|---|---|
| PEG | -5.49 |
| Price to Sales | - |
| Price to Book Ratio | 2.39 |
| Enterprise Value to Revenue | 23437.67 |
| Enterprise Value to EBIT | 2.62 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 10, 2026
EPS Estimate
-$2.06
Consensus analyst estimateRevenue Estimate
$4,600
Consensus analyst estimateNext Earnings Call
Expected Date
March 11, 2027
EPS Estimate
-$1.98
Consensus analyst estimateRevenue Estimate
$7,833
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 74.83% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 9.58%▼ 42.17% |
|---|---|
| Total Invested | $21.91M▼ 87.09% |
| Investors Holding | 22▼ 69.00% |
About Lyell Immunopharma Inc
189 employees
